Pharmacists Optimizing Cancer Care and Support for Individuals Affected by Cancer
Pharmacists play a crucial role in optimizing cancer care by promoting and advancing hematology/oncology pharmacy. Organizations like HOPA focus on supporting pharmacy practitioners to provide better care for individuals with cancer. They emphasize core values of integrity, leadership, collaboration, innovation, responsiveness, and care. The vision is to ensure that every individual affected by cancer has a hematologist/oncology pharmacist on their care team. Additionally, the mission is to optimize the care of cancer patients through advancements in pharmacy practice. Understanding the financial burden and role of pharmacists in treating individuals with cancer is essential in improving patient outcomes and reducing disparities in care.
Download Presentation
Please find below an Image/Link to download the presentation.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author.If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.
You are allowed to download the files provided on this website for personal or commercial use, subject to the condition that they are used lawfully. All files are the property of their respective owners.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author.
E N D
Presentation Transcript
HOPA HOPA Pharmacists Optimizing Cancer Care
Sarah Scarpace Peters, PharmD, BCOP, MPH President Associate Professor Albany College of Pharmacy & Health Sciences Albany, NY 8/2016 2
HOPA Core Ideology To support pharmacy practitioners and promote and advance hematology/oncology pharmacy to optimize the care of individuals affected by cancer. 8/2016 3
HOPA Core Values Integrity Leadership Collaboration Innovation Responsive Caring 8/2016 4
HOPA Vision All individuals affected by cancer have a hematology/oncology pharmacist as an integral member of their care team. Recognized as leading organization Considered premier organization for education/training Engaged and committed members Research and evidence-based approaches drive practice and direction of HOPA 8/2016 5
HOPA Mission To support pharmacy practitioners and promote and advance hematology/oncology pharmacy to optimize the care of individuals affected by cancer. 8/2016 6
Cost of Cancer 8/2016 http://www.bcbs.com/healthcare_costs/imag es/2015_Disease_costs.jpg 7
Causes of Financial Burden on Individuals with Cancer Zafara, S, J Peppercorna, D Schragb, D Taylor, A Goetzingerd, et al. The Financial Toxicity of Cancer Treatment: A pilot study assessing out-of-pocket expenses and the insured cancer patient s experience. Oncologist. 2013; 18(4): 381-90. http://theoncologist.alphamedpress.org/content/18/4/381.abstract 8/2016 8
Role of the Pharmacist in Treating the Cancer Patient Old Paradigm New Paradigm Primary Care Provider Oncology Nurse Pharmacist Patient Physician Patient Social Worker Oncologist Board-Certified Oncology Pharmacists: Their Potential Contribution to Reducing a Shortfall in Oncology Patient. Visits. http://www.ncbi.nlm.nih.gov/pubmed/27006358 Ignoffo R, et al. J Oncol Pract. 2016 Apr;12(4):e359-68. doi: 10.1200/JOP.2015.008490. Epub 2016 Mar 22. Caregiver 8/2016 9
The Role of the Hem/Onc Pharmacist Optimize outcomes by providing evidence-based, patient-centered medication therapy as part of an interdisciplinary team. Function effectively in oncology settings by participating in clinical investigations. Conduct research to: Advance oncology pharmacy practice Demonstrate the value of the hem/onc pharmacist 8/2016 10
The Role of the Hem/Onc Pharmacist Serve as an authoritative resource on the optimal use of medications to treat cancer patients. Provide training or educational activities for healthcare professionals and healthcare professionals in training. Manage and improve the medication use process in oncology. 8/2016 11
The Role of the Hem/Onc Pharmacist Promote health improvement, wellness, and cancer prevention. Sustain the ongoing development of expertise and professionalism in the practice of oncology pharmacy. 8/2016 12
HOPAs Membership Total Members: 2,527 42 International/ 16 Countries Represented in all 50 states Over 1,100 members are Board Certified Oncology Pharmacists (BCOP) 8/2016 13
HOPAs Membership Primary Responsibility Long Term Care 1% HMO/Managed Care 2% Other 7% Academic Center Industry 8% Ambulatory Care Center Government 4% Community Cancer Center Community Hospital Academic Center 34% Government Community Hospital 14% HMO/Managed Care Industry Long Term Care Ambulatory Care Center 15% Community Cancer Center 15% Other 8/2016 14
HOPAs Membership Student 2% Primary Position Technician 1% Resident/Fellow 12% Clinical coordinator 2% Clinical 2% Clinical Research Pharmacists 3% Clinical coordinator Clinical Pharmacists Professor 3% Manager/Director Other Clinical Pharmacists 19% Pharmacy Director 2% Oncology Pharmacists Clinical Patient Oncology Pharmacists Dispensing Oncology Pharmacists Dispensing 12% Manager/Director 8% Pharmacy Director Professor Other 6% Research Pharmacists Resident/Fellow Oncology Pharmacists Clinical Patient 28% Student Technician 8/2016 15
HOPAs Membership BCNSP 2% BCACP 2% BCNP 1% Certifications BCPS 23% BCACP BCNP BCPP 1% BCNSP BCOP BCPP BCPS BCOP 71% 8/2016 16
HOPAs Strategic Direction 8/2016 17
HOPA Strategic Plan Goal Area 1 : Professional Development Objectives: 1. Increase the breadth, depth and awareness of HOPA s educational initiatives to meet the diverse needs of pharmacists practicing in hematology/oncology. 2. Provide professional development opportunities that advance hematology/oncology pharmacists in leadership, research and advocacy. 3. Implement innovative delivery channels to maximize access to HOPA s professional development programs. 8/2016 18
HOPA Strategic Plan Goal Area 2: Professional Resources and Tools Objectives: 1. Develop best practices and practice standards. 2. Develop competencies and assessment tools to meet the needs of the membership. 3. Define, establish and develop a resource library for common practice challenges. 8/2016 19
HOPA Strategic Plan Goal Area 3: Research Objectives: 1. HOPA develops a research framework that demonstrates the value of hematology/oncology pharmacy. 2. Develop professional benchmarks for workforce metrics, quality improvement and professional practices. 3. Foster collaborative outcomes research that demonstrates the efficacy of hematology/oncology pharmacy. 4. Expand research funding through alternative sources. 8/2016 20
HOPA Strategic Plan Goal Area 4: Advocacy Objectives: 1. Strengthen and develop alliances to influence safety, quality and access to care. 2. Increase HOPA member engagement in advocacy initiatives. 3. Increase patient, public and professional awareness of the role and value of the hematology/oncology pharmacist. 8/2016 21
HOPAs Reach Physicians and PAs Multi- Stakeholder Pharmacists Nurses AACP* AMCP* APhA* ASHP* COA/COPA ISOPP JCPP APAO ASCO ASPHO ONS APHON ACCC APSHO Cancer Moonshot Cancer Support Community LiveStrong Pharmacy Workforce Commission Prevent Cancer Foundation * JCPP Members 8/2016 22
Shared Vision JCPP Patients achieve optimal health and medication outcomes with pharmacists as essential and accountable providers within patient- centered, team-based healthcare. HOPA All individuals affected by cancer have a hematology/oncology pharmacist as an integral member of their care team. 8/2016 23
Strategic Mapping JCPP s Goal Areas Establishing, implementing and promoting a consistent patient care process that is scalable and viable Understanding and recognizing the evidence that demonstrates and validates the value of pharmacists patient care services Integrating quality measures into pharmacy services Ensuring access to health information technology (HIT) Obtaining universal access to and coverage for pharmacists patient care services HOPA s Goal Areas Professional Development HOPA develops hematology/oncology pharmacists to be valuable members of the cancer care team exceling within their institutes and their profession. Professional Resources and Tools HOPA provides the professional resources and tools needed to support hematology/oncology pharmacy across the cancer care continuum. Research Establish HOPA as a leader in research of hematology/oncology pharmacy intervention and impact. Advocacy HOPA advocates for the value of hematology/oncology pharmacy and is an influential voice for patients' cancer care issues. 8/2016 24
Future Role of Hem/Onc Pharmacists Oncology clinical pharmacists are granted provider status Drivers of change in hematology/oncology pharmacy Equal and valued members of multi-disciplinary healthcare teams for all cancer patients Asked for by name 8/2016 25
Benefit to Pharmacy Profession and Health System Uniting the voice of the profession Fostering professional collaboration Furthering common professional goals Including the specialist perspective in the conversation Connecting to the broader healthcare community 8/2016 26
Thank you! Questions? 8/2016 27
